Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

IntelliPharmaCeutics International Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

05 Feb 2016 Reuters Investment Profile 12 $20.00

IntelliPharmaCeutics International Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 Feb 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - IntelliPharmaCeutics International Inc (I-T)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

11 Feb 2016 Thomson Reuters Stock Report 11 $25.00

Intellipharmaceutics International: Alpha Deal Group Intelligence

Alpha Deal Group considers Intellipharmaceutics International Inc. (NASDAQ: IPCI, TSX: I) as a unique opportunity for investo...

09 Feb 2016 Alpha Deal Group Intelligence Brief 33 $50.00

Wright Investors Service Comprehensive Report for Intellipharmaceutics International Incorporation

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

08 Feb 2016 Wright Reports 55 $75.00

ValuEngine Rating and Forecast Report for IPCI

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

07 Feb 2016 ValuEngine, Inc. 11 $25.00

INTELLIPHARMACEUTICS INTL INC (IPCI=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

06 Feb 2016 Pechala's Reports 2 $25.00

IntelliPharmaCeutics International Inc.: Downgraded to Below Average

02 Feb 2016 Sadif Analytics Prime 3 $10.00

Intellipharmaceutics International Inc. (I) - Financial Analysis Review

Intellipharmaceutics International Inc. (I) - Financial Analysis Review Summary Intellipharmaceutics International Inc. (Inte...

21 Jan 2016 GlobalData 43 $300.00

Is Now the Time to Buy IntelliPharmaCeutics International Inc.?

21 Jan 2016 Sadif Analytics Prime 12 $25.00